SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001638599-18-000573
Filing Date
2018-05-23
Accepted
2018-05-23 20:23:42
Documents
1
Period of Report
2018-05-23

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc3_5428.html 3  
1 PRIMARY DOCUMENT doc3_5428.xml 3 1522
  Complete submission text file 0001638599-18-000573.txt   2891
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38492 | Film No.: 18856389

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Issuer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations